Robeco Institutional Asset Management B.V. reduced its holdings in shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 4.5% during the second quarter, according to the company…
Read more Robeco Institutional Asset Management B.V. Sells 7,276 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)Neurocrine Biosciences Inc. Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company. It discovers, develops, and intends to commercialize drugs for the treatment of neurological and endocrine related diseases…
Read more NBIX Stock Price | Neurocrine Biosciences Inc. Stock Quote (U.S.: Nasdaq) | MarketWatchShares of Voyager Therapeutics Inc. VYGR, +10.65% rallied 35% in premarket trading on Monday after the company announced a deal with Neurocrine Biosciences Inc. NBIX, +0.06% to develop…
Read more Voyager, Neurocrine ink gene-therapy deal
